CX Institutional’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.4M Buy
28,717
+1,494
+5% +$1.16M 0.78% 29
2025
Q1
$22.5M Buy
27,223
+3,600
+15% +$2.97M 0.85% 27
2024
Q4
$18.2M Buy
23,623
+4,452
+23% +$3.44M 0.72% 33
2024
Q3
$17M Sell
19,171
-408
-2% -$361K 0.75% 30
2024
Q2
$17.7M Sell
19,579
-944
-5% -$855K 0.83% 30
2024
Q1
$16M Buy
20,523
+1,429
+7% +$1.11M 0.77% 33
2023
Q4
$11.1M Sell
19,094
-2,903
-13% -$1.69M 0.6% 46
2023
Q3
$11.8M Sell
21,997
-8,330
-27% -$4.47M 0.65% 46
2023
Q2
$14.2M Buy
30,327
+50
+0.2% +$23.4K 0.74% 29
2023
Q1
$10.6M Buy
30,277
+14,029
+86% +$4.89M 0.56% 42
2022
Q4
$5.94M Buy
16,248
+10,183
+168% +$3.73M 0.36% 67
2022
Q3
$1.96M Buy
6,065
+705
+13% +$228K 0.14% 185
2022
Q2
$1.74M Buy
5,360
+625
+13% +$203K 0.13% 187
2022
Q1
$1.36M Buy
4,735
+412
+10% +$118K 0.11% 194
2021
Q4
$1.19M Buy
4,323
+88
+2% +$24.3K 0.09% 187
2021
Q3
$979K Sell
4,235
-42
-1% -$9.71K 0.08% 215
2021
Q2
$982K Sell
4,277
-9,808
-70% -$2.25M 0.08% 201
2021
Q1
$2.63M Buy
14,085
+3,351
+31% +$626K 0.24% 105
2020
Q4
$1.81M Sell
10,734
-1,027
-9% -$173K 0.17% 163
2020
Q3
$1.74M Buy
11,761
+582
+5% +$86.2K 0.19% 146
2020
Q2
$1.84M Buy
11,179
+260
+2% +$42.7K 0.24% 115
2020
Q1
$1.52M Buy
10,919
+8,293
+316% +$1.15M 0.25% 88
2019
Q4
$345K Sell
2,626
-41
-2% -$5.39K 0.06% 169
2019
Q3
$298K Sell
2,667
-1,318
-33% -$147K 0.05% 195
2019
Q2
$441K Buy
3,985
+427
+12% +$47.3K 0.07% 168
2019
Q1
$462K Buy
3,558
+1,114
+46% +$145K 0.08% 161
2018
Q4
$283K Buy
+2,444
New +$283K 0.06% 151